Related references
Note: Only part of the references are listed.Smart Nano-PROTACs Reprogram Tumor Microenvironment for Activatable Photo-metabolic Cancer Immunotherapy
Chi Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)
Semiconducting Polymer Nano-regulators with Cascading Activation for Photodynamic Cancer Immunotherapy
Shasha He et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)
Microbiotic nanomedicine for tumor-specific chemotherapy-synergized innate/adaptive antitumor immunity
Wencheng Wu et al.
NANO TODAY (2022)
Near-Infrared II Nanoadjuvant-Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD-L1 Blockade to Enhance Antitumor Immunity
Qinyanqiu Xiang et al.
SMALL (2022)
Regulating trained immunity with nanomedicine
Mandy M. T. van Leent et al.
NATURE REVIEWS MATERIALS (2022)
Activatable Cancer Sono-Immunotherapy using Semiconducting Polymer Nanobodies
Ziling Zeng et al.
ADVANCED MATERIALS (2022)
Mitochondrial targeted melanin@mSiO2 yolk-shell nanostructures for NIR-II-driven photo-thermal-dynamic/immunotherapy
Yu Zhang et al.
CHEMICAL ENGINEERING JOURNAL (2022)
NIR-II laser-mediated photo-Fenton-like reaction via plasmonic Cu9S8 for immunotherapy enhancement
Lu An et al.
NANO TODAY (2022)
Starvation therapy enabled switch-on NIR-II photothermal nanoagent for synergistic in situ photothermal immunotherapy
Yinying Pu et al.
NANO TODAY (2022)
Framework Nucleic Acid Immune Adjuvant for Transdermal Delivery Based Chemo-immunotherapy for Malignant Melanoma Treatment
Fengyun Shen et al.
NANO LETTERS (2022)
Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodulatory nanoparticles
Jingchao Li et al.
NATURE COMMUNICATIONS (2022)
Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy
Han Jiang et al.
BIOMATERIALS (2022)
Second Near-Infrared Photothermal Semiconducting Polymer Nanoadjuvant for Enhanced Cancer Immunotherapy
Jingchao Li et al.
ADVANCED MATERIALS (2021)
Corn-like Au/Ag nanorod-mediated NIR-II photothermal/photodynamic therapy potentiates immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment
Liangjie Jin et al.
BIOMATERIALS (2021)
Considerations for designing preclinical cancer immune nanomedicine studies
Wen Jiang et al.
NATURE NANOTECHNOLOGY (2021)
A Polymer Multicellular Nanoengager for Synergistic NIR-II Photothermal Immunotherapy
Cheng Xu et al.
ADVANCED MATERIALS (2021)
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
Yuyan Jiang et al.
NATURE COMMUNICATIONS (2021)
ATP-Responsive Smart Hydrogel Releasing Immune Adjuvant Synchronized with Repeated Chemotherapy or Radiotherapy to Boost Antitumor Immunity
Lele Sun et al.
ADVANCED MATERIALS (2021)
Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
Chi Zhang et al.
NATURE COMMUNICATIONS (2021)
Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets
Quanyin Hu et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Second Near-Infrared Light-Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer Therapy
Cheng Xu et al.
ADVANCED MATERIALS (2021)
Cytosolic NQO1 Enzyme-Activated Near-Infrared Fluorescence Imaging and Photodynamic Therapy with Polymeric Vesicles
Chenzhi Yao et al.
ACS NANO (2020)
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Colorectal Tumor Microenvironment-Activated Bio-Decomposable and Metabolizable Cu2O@CaCO3Nanocomposites for Synergistic Oncotherapy
Mengyu Chang et al.
ADVANCED MATERIALS (2020)
Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy
Liwei Jiang et al.
CELL (2020)
A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy
Jun Xu et al.
NATURE NANOTECHNOLOGY (2020)
Recent Progress on Activatable Nanomedicines for Immunometabolic Combinational Cancer Therapy
Chi Zhang et al.
SMALL STRUCTURES (2020)
Molecular and nanoengineering approaches towards activatable cancer immunotherapy
Chi Zhang et al.
CHEMICAL SOCIETY REVIEWS (2020)
Bioinspired and Biomimetic Nanomedicines
Zhaowei Chen et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy
Yinchu Ma et al.
ACS NANO (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Organic Semiconducting Agents for Deep-Tissue Molecular Imaging: Second Near-Infrared Fluorescence, Self-Luminescence, and Photoacoustics
Qingqing Miao et al.
ADVANCED MATERIALS (2018)
Physical activation of innate immunity by spiky particles
Ji Wang et al.
NATURE NANOTECHNOLOGY (2018)
Near-infrared fluorophores for biomedical imaging
Guosong Hong et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Designing nanomedicine for immuno-oncology
Wen Jiang et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach
Yao Lu et al.
CANCER LETTERS (2016)
Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy
Chao Liang et al.
CHEMICAL SOCIETY REVIEWS (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells
Joao Conde et al.
ADVANCED FUNCTIONAL MATERIALS (2015)
A holistic approach to targeting disease with polymeric nanoparticles
Christopher J. Cheng et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Cell-Penetrating Hyperbranched Polyprodrug Amphiphiles for Synergistic Reductive Milieu-Triggered Drug Release and Enhanced Magnetic Resonance Signals
Xianglong Hu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Polyprodrug Amphiphiles: Hierarchical Assemblies for Shape-Regulated Cellular Internalization, Trafficking, and Drug Delivery
Xianglong Hu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Applications of nanotechnology for immunology
Douglas M. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Control of granzymes by serpins
D. Kaiserman et al.
CELL DEATH AND DIFFERENTIATION (2010)
Serpins in T cell immunity
Michael Bots et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma
IS van Houdt et al.
CLINICAL CANCER RESEARCH (2005)
SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity
M Bots et al.
BLOOD (2005)
Tumour-cell invasion and migration: Diversity and escape mechanisms
P Friedl et al.
NATURE REVIEWS CANCER (2003)
The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency
CE Hirst et al.
JOURNAL OF IMMUNOLOGY (2003)
Functional significance of the perforin/granzyme cell death pathway
JA Trapani et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
BA Bladergroen et al.
BLOOD (2002)
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors
JP Medema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses
MS Buzza et al.
CELLULAR IMMUNOLOGY (2001)